Cyclo Therapeutics to Present at the 2022 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation

Author's Avatar
Jun 21, 2022

Cyclo+Therapeutics%2C+Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that Professor Caroline Hastings, MD will present at the 2022+NPC+Conference hosted by the Australian NPC Disease Foundation being held virtually June 23-24, 2022.